This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genzyme Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Helen Yeoman: Innovator in Pharmaceutical Chemistry
Introduction
Helen Yeoman is a notable inventor based in Bridgewater, NJ (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address critical health issues.
Latest Patents
Helen Yeoman holds 1 patent for her work on arylamides and methods of use thereof. The patent describes substituted aryl amide compounds, which are pharmaceutically acceptable salts and pharmaceutical preparations. These compounds are particularly relevant in treating diseases and conditions mediated by deficient CFTR activity, with a focus on cystic fibrosis.
Career Highlights
Helen is currently employed at Genzyme Corporation, where she continues to advance her research and development efforts. Her work has been instrumental in creating innovative solutions for complex medical challenges.
Collaborations
Throughout her career, Helen has collaborated with esteemed colleagues, including Bertrand Vivet and Andrew Scholte. These partnerships have fostered a collaborative environment that enhances the impact of her research.
Conclusion
Helen Yeoman's contributions to pharmaceutical chemistry and her innovative approach to addressing health issues make her a significant figure in her field. Her work continues to inspire advancements in medical treatments.